.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The FDA recently highlighted a significant Boston Scientific heart recall affecting various cardiac devices. This regulatory action follows reports of several deaths and thousands of serious injuries. Therefore, clinicians must stay informed about the required corrections. However, the FDA does not recommend removing the devices from patients. Instead, doctors should update the software during scheduled clinic visits. Consequently, this measure aims to mitigate risks without invasive surgery.
The affected hardware includes the Accolade, Essentio, and Proponent models, among others. Specifically, these pacemakers and cardiac resynchronization therapy devices require the Brady SMR6 software patch. Boston Scientific developed this patch to fix issues stemming from a previous software version. Furthermore, the agency is monitoring additional updates regarding a potential battery drain issue. Thus, timely intervention is essential for patient safety.
Doctors must prioritize patients who are at higher risk. For instance, individuals with low battery life or those who rely entirely on the device need immediate follow-up. In addition, routine monitoring remains standard for other patients. Because the recall is Class I, the risks of inaction are severe. Consequently, medical teams should coordinate these updates promptly. This proactive approach ensures that the devices function correctly and prevent future complications.
Q1: Do these devices need to be surgically removed?
No, the FDA does not recommend device explant. Instead, a software update during an in-person clinic visit is sufficient to address the issue.
Q2: Which models are affected by this recall?
The recall involves the Accolade, Essentio, Proponent, Altrua 2, Valitude, and Visionist pacemakers and CRT devices.
Q3: What is the risk if the software is not updated?
Failure to update the software can lead to serious injury or death, as the correction fixes critical logic errors.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Boston Scientific issues a Class I recall for pacemakers like Accolade and Proponent. Software updates are required to address serious safety issues and dea...
5 months ago
Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today
A cross-sectional study reveals that maternal RSV vaccination coverage reached only 43.7% in Argentina, with maternal vaccine knowledge being the sole independent predictor of uptake. Clinicians play a crucial role in eliminating informational and structural barriers to optimize infant health.
Today
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday
